Treatment with Once-Weekly Semaglutide 2.4 mg Improves Cardiometabolic Risk Factors in Adults with Overweight/Obesity and Type 2 Diabetes: STEP 2 Post-hoc Analysis
Lorraine1; Albon, Robert F Kushner2; Melanie Davies3; John E Deanfield4; W Timothy Garvey5; Ole Kleist Jeppesen6; Usman Khalid6; Mikhail Kosiborod7; Peter Norkjaer Laursen6; Domenica M Rubino8; Subodh Verma9